Risk-Based AI Algorithm Detects Cancer from Limited Number of Mammograms
By MedImaging International staff writers Posted on 01 Apr 2021 |
Illustration
A risk-based algorithm - based on clinical indication, breast symptoms, breast cancer history, and age – was found to successfully maximize cancer detection from limited mammograms.
In a unique study, researchers at the Kaiser Permanente Washington Health Research Institute (KPWHRI; Seattle, WA, USA) have found a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19. In one of the largest studies of its kind, the researchers looked at nearly 900,000 individuals and close to two million mammograms from 2014 to 2019 at more than 90 radiology facilities in the national Breast Cancer Surveillance Consortium.
They found that a risk-based algorithm - based on clinical indication, breast symptoms, breast cancer history, and age - successfully maximized cancer detection. The results showed that 12% of mammograms with “very high” and “high” cancer detection rates accounted for 55% of detected cancers, while 44% of mammograms with “very low” cancer detection rates accounted for 13% of detected cancers.
“What this means is that triaging individuals most likely to have cancer during periods of reduced capacity may be effective at detecting the most cancers with the fewest mammograms versus using a non-risk-based approach,” said Diana L. Miglioretti, professor and division chief of biostatistics at the UC Davis Department of Public Health Sciences and affiliate investigator with KPWHRI who led the study. “Whether it is due to unexpected new surges in COVID-19 cases prompting new lockdowns or other emergencies such as cyberattacks or natural disasters like wildfires, the study results provide important guidance for navigating through any crisis that could impact the availability of mammograms.”
Related Links:
Kaiser Permanente Washington Health Research Institute
In a unique study, researchers at the Kaiser Permanente Washington Health Research Institute (KPWHRI; Seattle, WA, USA) have found a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19. In one of the largest studies of its kind, the researchers looked at nearly 900,000 individuals and close to two million mammograms from 2014 to 2019 at more than 90 radiology facilities in the national Breast Cancer Surveillance Consortium.
They found that a risk-based algorithm - based on clinical indication, breast symptoms, breast cancer history, and age - successfully maximized cancer detection. The results showed that 12% of mammograms with “very high” and “high” cancer detection rates accounted for 55% of detected cancers, while 44% of mammograms with “very low” cancer detection rates accounted for 13% of detected cancers.
“What this means is that triaging individuals most likely to have cancer during periods of reduced capacity may be effective at detecting the most cancers with the fewest mammograms versus using a non-risk-based approach,” said Diana L. Miglioretti, professor and division chief of biostatistics at the UC Davis Department of Public Health Sciences and affiliate investigator with KPWHRI who led the study. “Whether it is due to unexpected new surges in COVID-19 cases prompting new lockdowns or other emergencies such as cyberattacks or natural disasters like wildfires, the study results provide important guidance for navigating through any crisis that could impact the availability of mammograms.”
Related Links:
Kaiser Permanente Washington Health Research Institute
Latest Industry News News
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures
- Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases